ELRIG announces keynote speakers for Drug Discovery 2025
Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'
Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'
The Adeno-Associated Virus will be used in a Phase 1 trial in patients with advanced, high-risk acute myeloid leukemia.
Successful project delivery of Optimer binders with proven function as vaccine adjuvants
Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signalling
Redipor by AnalytiChem combining 150+ years of expertise in high-quality prepared media, now manufactured in three production facilities worldwide
Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays
Find out how research at HUB Organoids is paving the way for more effective cancer therapeutics
Learn how acoustically levitating a diamond led to a breakthrough in biotech automation
Can the science of fats unlock a new avenue in diabetes care? UT Southwestern researchers are finding out
ELRIG appoints Dr. Del Trezise as Chair of the Board
Registration now open
Reduces common user errors by up to 40% and boosts out-of-the-box sensitivity by up to 80 times with MaxPeak Premier columns
The HPLC Pump Qualification Pack from TESTA Analytical Solutions is designed for regulated labs looking to qualify the operation and performance of their HPLC systems
The use of protein biomarkers in oncology is growing rapidly and offers real hope to patients with hard-to-treat cancers
Partnership follows successful scale-up of CHO Edge System by LOTTE BIOLOGICS
Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from May 14–15
Digitalize your measurement processes in UV/Vis technology range
Find out how improved, easy to-use-features can reduce your laboratory’s plastic usage and waste costs